SP1 and atherosclerosis: High glucose or glucosamine can affect cardiovascular function by regulating Sp1 to increase the expression of plasminogen activator inhibitor-1 (PAI-1) and TGFβ, both of which are involved in atherosclerosis (Paueksakon et al., 2002; Issad and Kuo, 2008).